Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 September 1993 | Volume 119 Issue 6 | Page 539
Colorectal cancer tends to aggregate in families. A small fraction of these families have adenomatous polyposis coli caused by inherited mutations in the APC gene on chromosome 5q [1]. Hereditary nonpolyposis colon cancer is more common although heterogeneous and difficult to define [2]. We recently identified a family with exceptionally prominent features of the Muir-Torre syndrome, a clinically distinct form of hereditary nonpolyposis colon cancer characterized by sebaceous neoplasms of the skin and associated with cancers of the colon, rectum, and genitourinary tract [3].
LETTER
The Familial Muir-Torre Syndrome
TO THE EDITOR:
|
Patient II-3 developed at least nine primary cancers of the stomach, duodenum, jejunum, colon, and rectum during a 29-year period. In addition, several villous adenomas of the colon and two cutaneous sebaceous adenomas were excised. Cancers in patients with the Muir-Torre syndrome are reported to have an indolent course, even after metastases have developed [3]. The syndrome occurs in an autosomal dominant pattern in some families, but clustering of multiple primary cancers among several relatives is rare. To confirm the diagnosis of the Muir-Torre syndrome, dermatologic consultation was requested for our proband and his cousin (patient III-15). Skin biopsy specimens showed previously unsuspected sebaceous adenomas in both patients.
Sebaceous adenoma identifies the subset of families with hereditary nonpolyposis colon cancer who have the Muir-Torre syndrome and those at increased cancer risk. These family members should be monitored to detect early cancers and perhaps should be enrolled in chemoprevention trials. Genetic studies can help identify the inherited molecular defect that causes the Muir-Torre syndrome.
References
|
|---|
|
|
|---|
1. Peltomaki P, Sistonen P, Mecklin JP, Pylkkanen L, Aaltonen L, Nordling S, et al. Evidence that the MCC-APC gene region in 5q21 is not the site for susceptibility to hereditary nonpolyposis colorectal carcinoma. Cancer Res. 1992; 52:4530-3.
2. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990; 113:779-88.
3. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med. 1991; 90:606-13.
About Letters
|
|
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
This article has been cited by other articles:
![]() |
T. Yeo, J Kintner, R Armand, R Perez, and L. Lewis Sublethal concentrations of gemcitabine (2',2'-difluorodeoxycytidine) alter mitochondrial ultrastructure and function without reducing mitochondrial DNA content in BxPC-3 human pancreatic carcinoma cells Human and Experimental Toxicology, December 1, 2007; 26(12): 911 - 921. [Abstract] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||